恒润达生-话题@MedSci

#恒润达生#

3篇内容 | 702人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1601242, encodeId=3fa31601242b5, content=<a href='/topic/show?id=724b52821bb' target=_blank style='color:#2F92EE;'>#恒润达生#</a>, objectTitle=恒润达生CD19/CD22双靶点CAR-T疗法获批临床, objectType=article, longId=205478, objectId=80262054e8b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80262054e8b4, replyNumber=0, likeNumber=31, createdTime=2021-01-09, rootId=0, userName=30397610, userId=a70a18859615, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80262054e8b4, moduleTitle=恒润达生CD19/CD22双靶点CAR-T疗法获批临床, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80262054e8b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1601241, encodeId=4bce1601241e0, content=<a href='/topic/show?id=724b52821bb' target=_blank style='color:#2F92EE;'>#恒润达生#</a>, objectTitle=恒润达生完成2亿元B+轮融资，加码细胞治疗产业化布局, objectType=article, longId=200422, objectId=3705200422bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3705200422bf, replyNumber=0, likeNumber=30, createdTime=2020-09-09, rootId=0, userName=30397610, userId=a70a18859615, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3705200422bf, moduleTitle=恒润达生完成2亿元B+轮融资，加码细胞治疗产业化布局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3705200422bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1601240, encodeId=9dac16012404d, content=<a href='/topic/show?id=724b52821bb' target=_blank style='color:#2F92EE;'>#恒润达生#</a>, objectTitle=恒润达生完成2亿元B轮融资, objectType=article, longId=180345, objectId=499418034554, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=499418034554, replyNumber=0, likeNumber=34, createdTime=2019-10-02, rootId=0, userName=30397610, userId=a70a18859615, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=499418034554, moduleTitle=恒润达生完成2亿元B轮融资, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=499418034554)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

恒润达生

2020-05-29

30397610 (审核中...)

前往app查看评论内容

#恒润达生#

恒润达生CD19/CD22双靶点CAR-T疗法获批临床

2021-01-09

30397610 (审核中...)

前往app查看评论内容

#恒润达生#

恒润达生完成2亿元B+轮融资，加码细胞治疗产业化布局

2020-09-09

30397610 (审核中...)

前往app查看评论内容

#恒润达生#

恒润达生完成2亿元B轮融资

2019-10-02

科室
- - 订阅+
  - 更多科室
工具
服务